<DOC>
	<DOCNO>NCT01594957</DOCNO>
	<brief_summary>This study compare pharmacokinetics LCQ908 subject vary degree hepatic impairment healthy subject .</brief_summary>
	<brief_title>Pharmacokinetics LCQ908 Patients With Hepatic Impairment</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Inclusion criterion : Individuals hepatic impairment • Hepatic impairment evidence ChildPugh score Mild hepatic impairment define ChildPugh Class A ( 56 point ) Moderate hepatic impairment define ChildPugh Class B ( 79 point ) Severe hepatic impairment define ChildPugh Class C ( 1015 point ) . Healthy subject • Good health determine . Exclusion criterion : All Individuals A past medical history clinically significant ECG abnormality family history prolong QTinterval syndrome . Female subject must non child bear potential use effective method contraception . Individuals hepatic impairment History drug alcohol abuse within 3 month prior dose . History presence significant uncontrolled disease major organ class . Any surgical medical condition hepatic impairment might alter drug metabolism . Healthy subject History presence significant uncontrolled disease major organ class . Any surgical medical condition hepatic impairment might alter drug metabolism . History presence hepatitis B C and/or positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C test result screening . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>LCQ908 ,</keyword>
	<keyword>Hepatic Impairment ,</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>